For the first time ever, women across the U.S. have access to a comfortable, convenient, and accurate at-home cervical cancer...
In this free webinar, learn how modeling and simulation can help navigate the Animal Rule in drug development. Attendees will...
In this free webinar, learn how modeling and simulation can help navigate the Animal Rule in drug development. Attendees will...
In this free webinar, learn how modeling and simulation can help navigate the Animal Rule in drug development. Attendees will...
Recordati Joins Boehringer Ingelheim Venture Fund in Financing Round, with Participation from Delos and Blue Bay CapitalNew Investment, Combined with...
Recordati Joins Boehringer Ingelheim Venture Fund in Financing Round, with Participation from Delos and Blue Bay CapitalNew Investment, Combined with...
Recordati Joins Boehringer Ingelheim Venture Fund in Financing Round, with Participation from Delos and Blue Bay CapitalNew Investment, Combined with...
BOSTON and HOUSTON, Jan. 7, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The...
BOSTON and HOUSTON, Jan. 7, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The...
BOSTON and HOUSTON, Jan. 7, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The...
Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by leveraging generative chemistry design...
Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by leveraging generative chemistry design...
Upcoming free, educational webinars from Xtalks will feature topics on clinical trials, drug discovery & development, medical device and pharma manufacturing...
Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by leveraging generative chemistry design...
Upcoming free, educational webinars from Xtalks will feature topics on clinical trials, drug discovery & development, medical device and pharma manufacturing...
Upcoming free, educational webinars from Xtalks will feature topics on clinical trials, drug discovery & development, medical device and pharma manufacturing...
FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject clinical trial ESTERO, FL...
Clinical Trials in Cancer Cachexia, Inflammatory Bowel Disease and Retinal Disorders are Planned MONTVALE, N. J., Jan. 07, 2026 (GLOBE...
HOUSTON, Jan. 07, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued...
PALI-2108 is the first and only PDE4 inhibitor in development designed for targeted delivery to the terminal ileum and colon,...